Awards and Honors 2014
Temple-Fox Chase Bone Marrow Transplant Program Designated as a MDS Center of Excellence
The Temple-Fox Chase Bone Marrow Transplant Program is one of only four facilities in Pennsylvania to hold this distinction, bestowed by the Myelodysplastic Syndromes (MDS) Foundation, which recognizes institutions for expertise in myelodysplastic syndromes—a group of cancers affecting the bone marrow and blood; ongoing research, including IRB-approved clinical trials in this area; and documentation of peer-reviewed publications in this field.
Temple-Fox Chase Bone Marrow Transplant Program Earns Reaccreditation by FACT Accreditation
The Temple-Fox Chase Bone Marrow Transplant Program recently earned reaccreditation for three years from the Foundation for the Accreditation of Cellular Therapy (FACT). This achievement reaffirms the expertise and dedication of the faculty and the high quality of care provided to patients through the hematology program. FACT is the only accrediting organization that addresses all quality aspects of cellular therapy treatments: clinical care, donor management, cell collection, cell processing, cell storage and banking, cell transportation, cell administration, cell selection, and cell release.
Breast Cancer Patient Care Team Recognized by Susan G. Komen Philadelphia
Fox Chase Cancer Center as well as our Breast Cancer Patient Care Team was honored with the 2014 Beacon of Hope and the 2014 Lights of Life awards, respectively at the Komen Foundation’s Pink Thai Ball on October 18 at Vie in Philadelphia. The awards recognize Fox Chase’s pioneering history in cancer care, as well as the continued leadership and dedication of our faculty and staff to bringing both survival and hope to our community and beyond. Members of the breast team include: Richard J. Bleicher, MD, FACS; Marcia Boraas, MD, FACS; John Michael Daly, MD, FACS; Mary B. Daly, MD, PhD, FACP; Kathryn Evers, MD, FACR; Lori Goldstein, MD; Bonnie J. Miller, RN, BSN, OCN, FAAMA; Elin R. Sigurdson, MD, PhD, FACS; Jessie Schol, RN, BSN, OCN; and Kathryn Tumelty, MSN, AOCNP.
American Cancer Society Honors Fox Chase Cancer Center
Fox Chase Cancer Center has been recognized with the Partners in Health Initiatives Award at the Society’s Greater Philadelphia Area Volunteer Awards Celebration. The award acknowledges a high level of commitment to the mission of the American Cancer Society and is given to organizations that have demonstrated outstanding efforts to link the Society’s goals and priorities with the goals and priorities of the system that they represent. In addition, J. Robert Beck, MD, Senior Vice President and Deputy Director, Chief Academic Officer, and Chief Administrative Officer at Fox Chase, was honored with the 2014 Cancer Control Award and Jean-Pierre Issa, MD, Director of the Fels Institute for Cancer Research and Molecular Biology at Temple University School of Medicine, received the 2014 Scientific Research Award at this event.
(Jul 15, 2014)
Fox Chase Cancer Center has been ranked 19th among the nation’s top 50 hospitals for cancer care in U.S. News & World Report’s Best Hospitals 2014-2015 rankings. Fox Chase was also cited as high performing in the areas of nephrology, urology, and gynecology, as well as a new area – ear, nose, and throat.
Hilton Klein Receives 2014 AALAS Joseph J. Garvey Management Award
Hilton Klein, DVM, Director of the Laboratory Animal Health Facility, has been selected by the Board of Trustees of the American Association for Laboratory Animal Science to receive the 2014 AALAS Joseph J. Garvey Management Award. The award recognizes an individual for outstanding accomplishments in administration, management, or the support of programs relating to the care, quality, or humane treatment of animals used in biomedical research.
Alfred G. Knudson Jr., MD, PhD Recognized for Groundbreaking Hypothesis of Cancer Causation
Alfred G. Knudson Jr., MD, PhD a distinguished Fox Chase scientist, was honored as part of the American Society of Clinical Oncology’s 50th anniversary as one of its “Oncology Luminaries” for his groundbreaking “two-hit” hypothesis of cancer causation. The honor recognizes exceptional individuals who have helped shape the field of oncology and have advanced progress against cancer.
Charlie Ma, PhD Selected as a 2014 Astro Fellow
Charlie Ma, PhD, Vice Chairman of Radiation Oncology and Director of Radiation Physics, has been selected as a 2014 ASTRO Fellow—a distinguished honor given in recognition of one’s leadership and significant service to the American Society for Radiation Oncology and for contributions to the field of radiation oncology.
(May 20, 2014)
Robert G. Uzzo, MD, FACS, chair of Fox Chase’s department of surgery, G. Willing “Wing” Pepper Chair in Cancer Research, and co-leader of the genitourinary cancer treatment team, received the 2014 Residents Committee Teaching Award from the American Urological Association at its annual meeting in May. The award recognizes Dr. Uzzo’s dedication to mentoring the next generation of urologic researchers.
Fifty-eight (58) Temple physicians have been named to Philadelphia magazine’s “Top Doctors” list for 2014. Physicians on the list were nominated by their professional peers, and practice at Temple University Hospital, Fox Chase Cancer Center and Jeanes Hospital.
(Mar 25, 2014)
Michael H. Levy, MD, PhD, vice chair of medical oncology and director of the Pain & Palliative Care Program, is being honored with the American Society of Clinical Oncology’s (ASCO) inaugural Excellence in Teaching Award at the organization’s 2014 Annual Meeting in Chicago this June. The award recognizes an individual who has had a demonstrable impact on his or her trainees and who has inspired and shaped the trainees’ practice of cancer medicine. The award underscores ASCO’s belief that teaching is as important to the future of cancer medicine as are research, care delivery, and clinical work.
Mohan Doss, PhD, MCCPM receives Outstanding Leadership Award
Mohan Doss, PhD, MCCPM, a medical physicist and associate professor of diagnostic imaging, received the Outstanding Leadership Award in the field of dose-response for 2014 by the International Dose-Response Society during the organization’s annual conference April 22-23 in Amherst, Mass. The award is given for outstanding work in the field of low dose-response in each of the following three areas: Outstanding Career Achievement, Outstanding New Investigator, and Outstanding Leadership.